|
Research Report On Anti-hbv Drug MarketPublished by: SunFAITH China Ltd. Published: Jul. 13, 2009 - 8 Pages Table of Contents
AbstractUnder the joint impact of four anti-HBV nucleoside drugs, i.e. lamivudine, adefovir dipivoxil, entecavir and Telbivudine, from 2001~2006, anti-HBV market of China’s sample hospitals in key cities grew at a speed of more than average 30%. It is no doubt that China’s anti-HBV drug will continue to develop rapidly in a period of time in the future. This report mainly classifies the current anti-HBV drugs, and analyzes the most important types of anti-HBV drug markets and demand markets.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||